3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
106
Neoplasms
14
Neoplasm Metastasis
14
Carcinoma, Non-Small-Cell Lung
4
Advanced Breast Cancer
4
Hereditary Sensory and Autonomic Neuropathies
3
Recurrence
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Multiple Endocrine Neoplasia Type 1
2
Endometrial Neoplasms
2
Breast Neoplasms, Male
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Solid Malignancies
1
Recurrent Uterine Corpus Carcinoma
1
Neoplasms by Site
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Locally Advanced (Inoperable) or Metastatic Breast Cancer
1
Lethal Congenital Contracture Syndrome 2
1
Hyperglycemia
1
Hormone Receptor Positive HER-2 Negative Breast Cancer
1
Hormone Receptor Positive Breast Cancer
1
HER2-positive Breast Cancer
1
Female Breast Carcinoma
1
Exanthema
1
Interventions
Gemcitabine
6
Irinotecan
4
130-nm albumin-bound paclitaxel
4
Cisplatin
3
Albumin-Bound Paclitaxel
3
napabucasin
2
Leucovorin
2
Imatinib Mesylate
2
Everolimus
2
Ascorbic Acid
2
spartalizumab
1
pralsetinib
1
pembrolizumab
1
dostarlimab
1
copanlisib
1
alectinib
1
Ramucirumab
1
Paclitaxel
1
NUC-1031
1
Levoleucovorin
1
KRN-330
1
HhAntag691
1
Fluorouracil
1
Cyclophosphamide
1
Capecitabine
1
Bevacizumab
1
5,10-methylenetetrahydrofolic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Digestive System Neoplasms
×
Fulvestrant
×
Clear all
No trials found.